Hemodynamics of cerebral arteries of infants with periventricular leukomalacia

Department of Pediatrics, Neonatology, and Congenital Disorders, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.
PEDIATRICS (Impact Factor: 5.47). 02/2006; 117(1):1-8. DOI: 10.1542/peds.2004-1719
Source: PubMed

ABSTRACT This study investigated the developmental changes in blood flow in each cerebral artery among infants with and without periventricular leukomalacia (PVL), to elucidate the time of onset of PVL.
Eight of 67 low birth weight infants were diagnosed through ultrasonography as having PVL with cyst formation. The mean cerebral blood flow velocities (CBFVs) in the anterior cerebral artery, middle cerebral arteries (MCAs), posterior cerebral arteries (PCAs), internal carotid arteries (ICAs), and basilar artery were measured with Doppler ultrasonography at postnatal days 0, 1, 2, 3, 4, 5, 7, 10, 14, 21, 28, 42, 56, and 70. Four of 8 infants with cyst formation and 1 of 59 infants without cyst formation developed cerebral palsy.
The mean CBFVs of infants with PVL were significantly lower in the anterior cerebral artery (days 14-70), the right MCA (days 14-70), the left MCA (days 14-70), the right PCA (days 7-70), the left PCA (days 5-70), the right ICA (days 7-70), the left ICA (days 7-70), and the basilar artery (days 14 and 28-70). The CBFVs in all arteries were also lower among those with PVL than among intact infants on day 0. The CBFVs increased postnatally in the PCAs of infants with intact brains, whereas they remained unchanged after day 14 or 21 among infants with PVL. There was a significant difference in the prevalence of cerebral palsy between the 2 groups.
We suggest that the total cerebral blood supply is decreased in cases of cystic PVL and that this reduction occurs just after birth, in a defined sequence, in the cerebral arteries. We conclude that the insult resulting in PVL might occur close to the time of birth.

Download full-text


Available from: Mohamed Hamed Hussein, Sep 29, 2015
30 Reads
  • Source
    • "The " thrifty phenotype " hypothesis proposes that the fetus adapts to IUGR by optimizing the use of a reduced nutrient supply (Simmons, 2006; French et al., 2009). Impaired cerebral blood flow (Fukuda et al., 2006), and hypoxia (Yesilirmak et al., 2007) have been reported in preterm born IUGR infants. Cattle are not a standard model organism for the study of IUGR or normal fetal brain development. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We examined levels of gene expression in the brains of bovine fetuses carrying a truncated MIMT1 allele, MIMT1(Del), shown to cause late abortion and stillbirth as a result of fetal growth restriction. MIMT1 is a non-protein coding gene that forms part of the imprinted PEG3 (paternally expressed gene 3) domain. Microarray analysis of brain cortex samples from mid-gestation MIMT1(Del/WT) bovine fetuses and wild-type siblings was performed to study the effect of fetal growth restriction on brain gene expression. Statistical analysis revealed 134 genes with increased mRNA levels and 22 with reduced levels in MIMT1(Del/WT) fetuses. Gene set enrichment analysis identified a relatively small number of significant functional clusters representing three major biological processes: response to oxidative stress, angiogenesis, and epithelial cell proliferation. Gene expression microarray analyses identified increased expression of VIPR2, HTRA1, S100A4 and MYH8 in fetuses carrying the deletion and decreased expression of DRD2, ADAM18, miR345, ZNF585A. ADAM18, DRD2 and S100A4 are known to be involved in prenatal brain development. ZNF585A, miR-345, VIPR2, HTRA1, MYH8 are known to be involved in cell growth and differentiation, but any role in neural developmental has yet to be elucidated.
    International journal of developmental neuroscience: the official journal of the International Society for Developmental Neuroscience 05/2013; 31(7). DOI:10.1016/j.ijdevneu.2013.05.003 · 2.58 Impact Factor
  • Source
    • "The pathogenesis of PWMI is complex and multifactorial. There is evidence linking PWMI with maternal and/or fetal infection (Hagberg et al, 2002; Dammann et al, 1997; DiSalvo 1998), hypoxia/ischemia (Yesilirmak et al, 2007), impaired regulation of cerebral blood flow (Fukuda et al, 2006), formation of free radicals (Haynes et al, 2005), impaired myelination due to oligodendrocyte injury/loss (Cai et al, 2000; Inder et al, 2000), apoptotic cell death (Kadhim et al, 2006), microglial activation (Volpe, 2001) and excitotoxicity (Follett et al, 2004). Despite growing literature detailing associations, very little detailed information exists about the cellular mechanisms by which PWMI occurs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Periventricular white matter injury (PWMI) is the leading cause of chronic neurologic injury among survivors of preterm birth. The hallmark of PWMI is hypomyelination and a lack of mature, myelinating oligodendrocytes. Oligodendrocytes undergo a well-characterized lineage progression from neural stem cell to mature oligodendrocyte. Oligodendrocyte precursors have increased susceptibility to oxidative and free radical-mediated injury compared with mature oligodendrocytes as a result of lower levels of antioxidant enzymes and free radical scavengers. In this study, we show that oxidative stress disrupts oligodendrocyte differentiation by two mechanisms. First, oxidizing agents decrease the expression of key genes that promote oligodendrocyte differentiation from neural stem cells and increase the expression of genes known to inhibit differentiation. Second, global histone acetylation persists under conditions of oxidative stress, further contributing to the prevention of oligodendrocyte differentiation. Both of these mechanisms result in the arrest of oligodendrocyte differentiation without an increase in cell death.
    Journal of Neuroscience Research 11/2009; 87(14):3076-87. DOI:10.1002/jnr.22139 · 2.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Periventricular leukomalacia (PVL), the dominant form of brain injury in premature infants, is characterized by white matter injury (WMI) and is associated with cerebral palsy. The pathogenesis of PVL is complex and likely involves ischemia/reperfusion, free radical formation, excitotoxicity, impaired regulation of cerebral blood flow, a procoagulant state, and inflammatory mechanisms associated with maternal and/or fetal infection. Using an established animal model of human PVL, we investigated whether activated protein C (APC), an anti-coagulant factor with anti-inflammatory, anti-apoptotic, anti-oxidant, and cytoprotective activities, could reduce endotoxin-induced WMI in the developing rat brain. Intraperitoneal injections of lipopolysaccharide (LPS) (0.5 mg/kg body weight) were given at embryonic days 18 (E18) and 19 (E19) to pregnant Sprague-Dawley rats; control rats were injected with sterile saline. A single intravenous injection of recombinant human (rh) APC (0.2 mg /kg body weight) was given to pregnant rats following the second LPS dose on embryonic day 19 (E19). Reduced cell death in white matter and hypomyelination were shown on TUNEL and myelin basic protein (MBP) staining, respectively, on late postnatal days (P7) in APC-treated groups. There were significantly fewer TUNEL+nuclei in the periventricular WM in the APC+LPS group than in the untreated LPS group. Compared to the APC+LPS and control group, MBP expression was weak in the LPS group on P7, indicating endotoxin-induced hypomyelination in the developing rat brain. APC attenuated the LPS-induced protein expression of inflammatory cytokines, tumor necrosis factor-alpha, and interleukin-6, as evaluated by ELISA in neonatal rat brains. A single intraperitoneal injection of rhAPC (0.2 mg/kg body weight) to neonatal rats on P1 also had similar protective and anti-inflammatory effects against maternally administered LPS. Collectively, these data support the hypothesis that APC may provide protection against an endotoxin-evoked inflammatory response and WMI in the developing rat brain. Moreover, our results suggest that the possible use of APC in treatment of preterm infants and pregnant women with maternal or placental infection may minimize the risk of PVL and cerebral palsy.
    Brain Research 09/2007; 1164(1):14-23. DOI:10.1016/j.brainres.2007.04.083 · 2.84 Impact Factor
Show more